{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:53:57Z","timestamp":1794106437522,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijgc.2025.101957","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T15:14:16Z","timestamp":1748445256000},"page":"101957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3210-9102","authenticated-orcid":false,"given":"Amy","family":"Jamieson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Huvila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Grube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1176-2622","authenticated-orcid":false,"given":"Andrea","family":"Neilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-2612","authenticated-orcid":false,"given":"Niki","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrane","family":"Nazeran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Anglesio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Senz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7889-8250","authenticated-orcid":false,"given":"C Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6003-485X","authenticated-orcid":false,"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijgc.2025.101957_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101957_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/PGP.0000000000000982","article-title":"Synchronous endometrial and ovarian carcinomas: pathologic and molecular analysis highlights the monoclonal origin of the lesions","volume":"43","author":"Guerriero","year":"2024","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101957_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv427","article-title":"Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas","volume":"108","author":"Schultheis","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101957_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ijc.32907","article-title":"Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome","volume":"147","author":"Reijnen","year":"2020","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101957_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv442","article-title":"Making a difference: distinguishing two primaries from metastasis in synchronous tumors of the ovary and uterus","volume":"108","author":"Dizon","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.ijgc.2025.101957_bib6","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/S1470-2045(24)00192-X","article-title":"Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer Intergroup","volume":"25","author":"Creutzberg","year":"2024","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101957_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101957_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ygyno.2004.05.006","article-title":"Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases","volume":"94","author":"Soliman","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101957_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2018.10.033","article-title":"Risk-based stratification of carcinomas concurrently involving the endometrium and ovary","volume":"152","author":"Turashvili","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101957_bib10","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e7","article-title":"Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma","volume":"30","author":"Yoneoka","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.101957_bib11","series-title":"NCCN Ovarian Cancer\/Fallopian Tube Cancer\/Primary Peritoneal Cancer","year":"32024"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101957_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynecol Obstet"},{"issue":"10","key":"10.1016\/j.ijgc.2025.101957_bib13","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/a-1545-4279","article-title":"2020 WHO Classification of Female Genital Tumors","volume":"81","author":"H\u00f6hn","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"15","key":"10.1016\/j.ijgc.2025.101957_bib14","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/cncr.34328","article-title":"Molecular classification in endometrial cancer: opportunities for precision oncology in a changing landscape","volume":"128","author":"Jamieson","year":"2022","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101957_bib15","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann Oncol"},{"issue":"29","key":"10.1016\/j.ijgc.2025.101957_bib16","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ijgc.2025.101957_bib17","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101957_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101957_bib19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101957_bib20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2019.07.012","article-title":"Molecular profiling and molecular classification of endometrioid ovarian carcinomas","volume":"154","author":"Cybulska","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"20","key":"10.1016\/j.ijgc.2025.101957_bib21","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1158\/1078-0432.CCR-20-1268","article-title":"Endometrial cancer molecular risk stratification is equally prognostic for endometrioid ovarian carcinoma","volume":"26","author":"Kr\u00e4mer","year":"2020","journal-title":"Clin Cancer Res."},{"issue":"3","key":"10.1016\/j.ijgc.2025.101957_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"issue":"14","key":"10.1016\/j.ijgc.2025.101957_bib23","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/cncr.33516","article-title":"Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: an individual patient data meta-analysis","volume":"127","author":"McAlpine","year":"2021","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101957_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100085","article-title":"Grade and estrogen receptor expression identify a subset of no specific molecular profile endometrial carcinomas at a very low risk of disease-specific death","volume":"36","author":"Jamieson","year":"2023","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.ijgc.2025.101957_bib25","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41416-023-02141-0","article-title":"Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry","volume":"128","author":"Vermij","year":"2023","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101957_bib26","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/his.15241","article-title":"The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile","volume":"85","author":"Alafraidi","year":"2024","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101957_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/PAS.0000000000001020","article-title":"Molecular classification of Grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups","volume":"42","author":"Bosse","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101957_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.6004\/jnccn.2022.7096","article-title":"Molecular profiling of endometrial cancer from TCGA to clinical practice","volume":"21","author":"Jamieson","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.ijgc.2025.101957_bib29","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jnci\/djab029","article-title":"Prevalence and prognosis of Lynch syndrome and sporadic mismatch repair deficiency in endometrial cancer","volume":"113","author":"Post","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.ijgc.2025.101957_bib30","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1136\/ijgc-2024-005916","article-title":"Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier","volume":"34","author":"Jamieson","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2025.101957_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ygyno.2023.05.073","article-title":"Harmonized molecular classification; assessment of a single-test ProMisE NGS tool","volume":"175","author":"Jamieson","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101957_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PAI.0000000000001089","article-title":"Intraindividual tumor heterogeneity of mismatch repair status in metastatic colorectal cancer","volume":"31","author":"Huang","year":"2023","journal-title":"Appl Immunohistochem Mol Morphol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25010771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25010771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T15:39:18Z","timestamp":1751643558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25010771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1048891X25010771"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101957","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"101957"}}